Bloodless Medicine and Surgery

Klem HG Allogeneic transfusion risks in the surgical patient Am J Surg 1995,170 21S-26S

Jackson RM , Rice DH Blood transfusion and recurrence in head and neck cancer Ann Otol Rhmol Laryngol 1989,98 171-173

Chung M. , Steinmetz OK , Gordon PH Perioperative blood transfusion and outcome after resection for colorectal carcinoma Br J Surg 1993,80 427-432

Vamvakas EC Perioperative blood transfusion and cancer recurrence metaanalysis for explanation Transfusion 1995, 35 760-768

Busch Orc , Marquet RL , Hop Wcj , et al Colorectal cancer recurrence and penoperarive blood transfusions a critical appraisal Semm Surg Oncol 1994,10 195-199

Heiss MM , Mempel W. , Delanoff C. , et al Blood transfusion-modulated tumor recurrence first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery J Clin Oncol 1994,12 1859-1861

Houbiers Jga , Van Brand A. , de Watering Lmg , et al Randomized controlled tnal companng transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer Lancet 1994,344 573-578

Weiskopf RB , Viele MK , Feiner J. , et al Human cardiovascular and metabolic response to acute, severe isovolemic anemia JAMA 1998,279 217-221

Fowler NO , Homes JC Blood viscosity and cardiac output in acute expenmental anemia J Appl Physiol 1975;39 453-456

Carson JL , Duff A. , Berlin JA , et al Perioperative blood transfusion and postoperative mortality JAMA 1998,279 199-205

Erslev AJ , Caro J. , Miller O. , et al Plasma erythropoietin in health and disease Ann Clm Lab Sci 1980,10 250-257

Miyake T. , Kung C. , Goldwasser E. Purification of human erythropoietin J Biol Chem 1977,252.5558-5564

Mufson RA , Gesner TG Binding and internalization of recombmant human erythropoietin in murine erythroid precursor cells Blood 1987,69.1485-1489

Eschbach JW , Egne JC , Downing MR , et al Correction of the anemia of end stage renal disease with recombmant human erythropoietin. N Engl J Med 1987,316 73-78

Valeri CR , Crowley JP , Loscalzo J. The red cell transfusion trigger Has a sin of commission now become a sin of omission ? Transfusion 1998;38 602-610

Kitchens CS Are transfusions overrated? Surgical outcome of Jehovah's Witnesses Am J Med 1993;94 117-119

Carson JL , Poses RM , Spence RK , et al. Seventy of anemia and operative mortality and morbidity Lancet 1988,1:727-729

Viele MK , Weiskopf RB What can we learn about the need for transfusion from patients who refuse blood. the experience with Jehovah's Witnesses Transfusion 1994,34 396-401

Spence RK , Carson JA , Poses R. Elective surgery without transfusion influence of preoperative hemoglobin level and blood loss on mortality Am J Surg 1990,159 320-324

Christopherson R. , Frank S. , Norns E. , et al Low postoperative hematocnt is associated with cardiac ischemia in high risk patients. Anesthesiology 1991;75 A99

Consensus Conference Perioperative red blood cell transfusion JAMA 1988,260 2700-2704

Silberstem LE , Kruskall MS , Stehling LC , et al Strategies for the review of transfusion practices. JAMA 1989;262 1993-1997

Anonymous. Practice strategies for elective red blood cell transfusion Clin Guide Am College Physicians 1992,116. 403-406

Spence RK Surgical red blood cell transfusion practice policies. Am J Surg 1995,170 3S-15S

Spence RK , McCoy S. , Costabile J. , et al Fluosol DA-20 in the treatment of severe anemia: randomized controlled study of 46 patients Crit Care Med 1990,18.1227-1230

Smoller BR , Kruskall MS Phlebotomy for diagnostic laboratory tests m adults pattern of use and effect on transfusion requirements. N Engl J Med 1986,314 1233-1235

Chnstenson JT , Maunce J. , Simonet F. , et al Normothermic versus hypothermic perfusion during primary coronary artery bypass grafting Cardiovasc Surg 1995,3 519-524

Salem M. , Chernow B. , Burke R. , et al Bedside diagnostic testing its precision, rapidity, and utility in blood preservation Cnt Care Med 1991,19 584

Silver MJ , Jubran H. , Stein S. , et al. Evaluation of a new blood-conserving arterial line system for patients in intensive care units Cnt Care Med 1993, 21 507-511

Dietz NM , Joyner MJ , Warner MA Blood substitutes: fluids, drugs, or miracle solutions? Anesth Analg 1996,82 390-405

Keatmg EM Current options and approaches for blood management in orthopaedic surgery . J Bone Joint Surg 1998, 80A:750-762

Gould SA , Rosen AL , Sehgal LR , et al Fluosol DA as a red cell substituted in acute anemia. N Engl J Med 1986,314. 1653-1656

Keipert PE Use of oxygent, a perfluorochemical-based oxygen carrier, as an alternative to intraoperative blood transfusion Artif Cells Blood Substit Immobil Biotechnol 1995,23: 381-394

Goldberg MA , McCutchen JW , Jove M. , et al A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery Am J Orthoped 1996;25 544-552

Rutherford CJ , Schneider T. , Dempsey H. , et al Efficacy of different dosing regimens for recombinant human erythropoietm in a simulated perisurgical setting the importance of iron availability Am J Med 1994 ,96 139-145

DeAndrade JR , Jove M. , Landon G. , et al Baseline hemoglobin as predictor of risk of transfusion and response to epoietin alfa in orthopedic surgery patients Am J Orthoped 1996, 25 533-542

Brugnara C. , Chambers LA , Malynn E. , et al Red blood cell regeneration induced by subcutaneous recombinant erythropoietin iron-deficient erythropoiesis in iron-replete subjects Blood 1993,81 956-963

Macdougall IC , Tucker B. , Thompson J. , et al A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int 1996,50 1694-1699

Auerbach M. , Witt D. , Toler W. , et al. Clinical use of the total dose infusion of iron dextran J Lab Clin Med 1988;111 566-570

Toy Ptcy , Menozzi D. , Strauss RG , et al. Efficacy of preoperative donation of blood for autologous use m radical prostatectomy Transfusion 1993;33:721-724

Ness PM , Bourke DL , Walsh PK A randomized tnal of pen-operative hemodilution vs transfusion of preoperatively deposited autologous blood in elective surgery Transfusion 1991,32 226-230

Dzik WH , Fleisher AG , Ciavarella D. , et al Safety and efficacy of autologous blood donation before elective aortic valve operation Ann Thorac Surg 1992 ,54 1177-1181

Mercunali F. , Zanella G. , Barosi G. , et al. Use of erythropoietm to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1992,33 55-60

Kyo S. , Omoto R. , Hirashima K. , et al Effect of human recombinant erythropoietm on reduction of homologous blood transfusion in open heart surgery Circulation 1992,86(suppl II) 413-418

Speiss BD , Sassetti R. , McCarthy R. , et al Autologous blood donation hemodynamics in a high-risk patient population Transfusion 1992;32:17-22

Aubuchon JP , Popovsky MA The safety of preoperative autologous blood donation in the non-hospital setting Transfusion 1991,31 513-517

Etchason J. , Petz L. , Keeler E. , et al The cost-effectiveness of preoperative autologous blood donations N Engl J Med 1995 ;332:719-724

Monk TG , Goodnough LT Blood conservation strategies to mimmize allogeneic blood loss in urologic surgery Am J Surg 1995,170 69S-73S

Goodnough LT , Grishaber JE , Birkmyer JD , et al Efficacy and cost effectiveness of autologous blood predeposit in patients undergoing radical prostatecotomy procedure Urology 1994;44:226-231

Domen RE Preoperative autologous blood donation: clinical, economic, and ethical issues Cleve Clin J Med 1996,63: 295-300

Blumberg N. , Kirkley SA , Heal JM A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery. Am J Surg 1996;171:324-330

Laks H. , Pilon RN , Klovekorn WP Acute hemodilution. its effects on hemodynamics and oxygen transport in anesthetized man Ann Surg 1974;180:103-110

Rose D. , Coutsoftides T. Intraoperative normovolemic hemodilution. J Surg Res 1981,31 375-381

Monk TG , Goodnough LT , Birkmeyer JD Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous blood donation by patients undergoing radical retropubic prostatectomy Transfusion 1995,35: 559-565

Bryson GL , Laupacis A. , Wells GA Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion ? A meta-analysis. Anesth Analg 1998;86:9-15

Sowade O. , Warnke H. , Scigalla P. , et al Avoidance of allogeneic blood transfusions by treatment with epoetm beta (recombmant human erythropoietin) in patients undergoing open-heart surgery Blood 1997,89 411-418

Monk TG , Goodnough LT , Brecher ME , et al Acute normovolemic hemodilution can replace preoperative autologous blood donation as a standard of care for autologous blood procurement in radical prostatectomy Anesth Analg 1997, 85 953-958

Spahn DR , Schmid ER , Burkhardt S. , et al Hemodilution tolerance in patients with coronary artery disease who are receiving chronic B-adrenergic blocker therapy Anesth Analg 1996,82 687-694

Spence RK , Alexander JB , DelRossi AJ , et al Transfusion guidelines for cardiovascular surgery lessons learned from operations in Jehovah's Witnesses J Vasc Surg 1992,16 825-831

Cooley DA Conservation of blood during cardiovascular surgery Am J Surg 1995,170 53S-59S

Karczewski DM , Lema MJ , Glaves D. The efficiency of an autotransfusion system for tumor cell removal from blood salvaged during cancer surgery Anesth Analg 1994,78: 1131-1135

Dale RF , Kipling RM , Smith MF , et al. Separation of malignant cells during autotransfusion Br J Surg 1988,75 581-586

Miller GV , Ramsden CW , Primrose JN Autologous transfusion an alternative to transfusion with banked blood during surgery for cancer Br J Surg 1991,78.713-715

Edelman MJ , Potter PJ , Mahaffey KG , et al. The potential reintroduction of tumor cells during intraoperative blood salvage reduction of risk with use of the RC-400 leucocyte depletion filter Urology 1996;47 179-181

Noon GP , Jones J. , Fehir K. , et al Use of preoperatively obtained platelets and plasma in patients undergoing cardiopulmonary bypass J Clin Aspheresis 1990,5.91-96

Christenson JT Platelet pheresis before re-do CABG diminished excessive blood transfusion Ann Thorac Surg 1996, 62 1373-1379

Mohr R. , Goor DA , Yellin A. , et al Fresh blood units contain large potent platelets that improve hemostasis after open heart operations Ann Thorac Surg 1992,53 650-654

Stover EP Platelet-rich plasma pheresis with therapeutic platelet yield reduces allogeneic red blood cell and platelet transfusions in high risk cardiac surgery Anesthesiology 1996,85 968

Nelson CL , Fontenot HJ Ten strategies to reduce blood loss in orthopedic surgery. Am J Surg 1995,170 64S-68S

Reed Rli , Johnson TD , Hudson JD , et al The disparity between hypothermic coagulopathy and clotting studies J Trauma 1992;33 465-470

Tanaka J. , Takao M. , Yada I. , et al Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery J Cardiothorac Vasc Anesth 1989; 3 181-188

Bidstrup BP , Hamson J. , Royston D. , et al Aprotinin therapy in cardiac surgery a report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg 1993,55 971-976

Havel MP , Griesmacher A. , Weigel G. , et al. Aprotonin m-creases release of von Willebrand factor in cultured human umbilical vein endothelial cells Surgery 1992,112.573-577

Mannucci PM Hemostatic drugs. N Engl J Med 1998;339: 245-253

Wilson JM , Bower LK , Fackler JC , et al Aminocaproic acid decreases the incidence of intracranial hemorrhage and other hemorrhagic complications of ECMO. J Pediatr Surg 1993,28.536-541

VanderSalm TJ Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid J Thorac Cardiovasc Surg 1996,112 1098-1107

Bartholomew JR , Salgia R. , Bell WR Control of bleeding with immune and non-immune thrombocytopenia with ammocaproic acid Arch Int Med 1989,149 1959-1961

Ereth MH , Oliver WC , Santrach PJ Perioperative mterventions to decrease transfusion of allogeneic blood products Mayo Clin Proc 1994,69 575-586

Horrow JC , Van Riper DF , Strong MD , et al Hemostatic effects of tranexamic acid and desmopression during cardiac surgery Circulation 1991,84 2063-2070

Mannucci PM Desmopression a nontransfusional form of treatment for congenital and acquired bleeding disorders Blood 1988,72:1449-1455

Guay J. , Remberg C. , Poitras B. , et al A trial of desmopression to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis Anesth Analg 1992,75 405-410

Hackmann T. , Gascoyne RD , Naiman SC , et al A tnal of desmopression (1-desamino-8d-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery N Engl J Med 1989,321:1437-1443

Fremes SE , Wong BI , Lee E. , et al Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding Ann Thorac Surg 1994 ,58.1580-1588

Grim PS , Gottlieb LJ , Boddie A. , et al Hyperbaric oxygen therapy JAMA 1990,263.2216-2220

Miller CB , Jones RJ , Piantadosi S. , et al Decreased erythropoietin response in patients with anemia of cancer. N Engl J Med 1990,322 1689-1692

Glaspy J. , Bukowski R. , Steinberg D. , et al Impact of therapy with epoietin alfa on clinical outcomes in patients with non-myeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol 1997;15:1218-1234

Kaufman DB , Sutherland Der , Fryd DS , et al. A single center experience of renal transplantation in thirteen Jehovah's Witnesses Transplantation 1988;45 1045-1049

Benson K. Management of the Jehovah's Witness oncology patient perspective of the transfusion service. Cancer Control J 1997;2 552-556

Fujita H. , Marute A. , Koharazawa H. , et al. Successful treatment of a Jehovah's Witness with acute promyelocytic leukemia. Int J Hematol 1997,65 415-416

Goldberg SL , Chan Csp , Dawkms FW , et al. Should Jehovah's Witnesses be denied intensive chemotherapy for acute leukemia ? N Engl J Med 1990;322 777-778

Damer PM , Knupp CL , Sartiano GP Low dose cytosine arabinoside as an alternative treatment for acute leukemia in Jehovah's Witnesses. Am J Hematol 1992,40:156-161.

Nousiainen T. , Jantunen E. , Lahtinen R. Jehovah's Witnesses and acute leukemia Am J Hematol 1993,43:158-163

Boggs DR Jehovah's Witnesses with leukemia. Hosp Prac (Off Ed) 1985,20 92-98

Cullis JO , Smith AG Jehovah's Witnesses with leukemia Lancet 1990 ,336 1075-1076

Hargis JG , Waddell DJ , Diehl L. , et al Induction chemotherapy in Jehovah's Witnesses with leukemia. Lancet 1990;336 563-564

Estrin JT , Ford PA , Henry DH , et al Erythropoietin permits high dose chemotherapy with penpheral blood stem-cell transplant for a Jehovah's Witness. Am J Hematol 1997;55: 51-54

Vernon S. Center for Bloodless Medicine and Surgery An Institutional Effect 1996 Poster presentation, IVth Annual Symposium, Critical Issues in Surgery, St Thomas, U.S Virgm Islands, December 2-4, 1996

Helm RE , Rosengart TK , Gomez M. , et al Comprehensive multimodality blood conservation 100 consecutive CABG operations without transfusion Ann Thorac Surg 1998;65 125-136